Xconomy

From Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs:

stevegillis2
stevegillis2

Steve Gillis is a managing director with Arch Venture Partners

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.